Summary
Introduction
Tienilic acid [2,3-dichloro-4-(2-thienyl-carbony1)phenoxyacetic acid] is a new diuretic with a chemical structure similar to that of ethacrynic acid and a diuretic potency comparable with that of thiazide agents (Masbenard, Guidicelli & Kamaludin, 1976 Lemieux, Gougoux, Vinary, Kiss & Baverel, 1978) .
In view of the potential renal and vascular damage caused by urate accumulation, the availability of a natriuretic uricosuric agent might be useful in the long-term therapy of hypertensive patients. In order to investigate the metabolic and antihypertensive effects of tienilic acid, compared with those of a currently used diuretic agent, we have carried out a double-blind trial in 28 hypertensive patients, who were randomly allocated to take tienilic acid or hydrochlorothiazide.
Patients and methods
Twenty-eight patients (1 5 males and 13 females, aged 18-66 years) with essential hypertension, WHO stage 0-1, were admitted to the study. Eleven patients had never been treated before; in the remaining 17 patients all antihypertensive drug therapy was discontinued at least 1 week before admission.
Fourteen patients (seven males and seven females) received tienilic acid, 250 mg/day in a single oral dose, and 14 patients (eight males and six females) received hydrochlorothiazide, 50 mg/day in a single oral dose. After 2 weeks of treatment, if the diastolic blood pressure had not decreased by at least 10 mmHg, the dose was doubled for a further 3 weeks. Final doses were 57 f 5 mg/day for hydrochlorothiazide and 303 k 28 mg/day for tienilic acid.
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Blood pressure, determined by sphygmomanometer, and pulse rate were measured supine and standing before admission and then every week in all patients. Laboratory analyses, namely urinalysis, plasma and urinary electrolytes, serum and urinary urea, creatinine and uric acid, plasma glucose, cholesterol and triglycerides, were carried out in all patients before and after 5 weeks of therapy (Autoanalyzer, Technicon). All the patients were informed of the investigational nature of the trial and gave their informed consent.
Student's paired t-test was used to test significance.
Results
Supine and standing systolic and diastolic blood pressures decreased similarly after 5 weeks in the two groups of patients ( Table 1) . Pulse rate was not significantly altered. The average initial dose ratio tienilic acid/hydrochlorothiazide was 5 : 1 and the average final dose ratio was 5 . 3 : l . A significant decrease in plasma chloride and slight but insignificant decreases in plasma sodium and potassium were observed with both drugs; no changes in serum urea, serum creatinine or creatinine clearance were observed. No differences were found between the two agents in influencing any of these variables. In patients receiving hydrochlorothiazide a significant increase in serum uric acid was found, and in the group of patients who received tienilic acid a significant decrease was observed. Uric acid clearance was not modified by hydrochlorothiazide, but doubled during therapy with tienilic acid.
The overall incidence of side-effects of the two drugs was similar: four patients (two on tienilic acid and two on hydrochlorothiazide) experienced tiredness and four patients (two on tienilic acid and two on hydrochlorothiazide) experienced tachycardia; one patient on tienilic acid complained of postural dizziness. None of these patients was withdrawn from the trial because of side-effects. cerides during tienilic acid therapy. In our patients we did not observe any significant variation: however, it is impossible to evaluate these data since no particular diet was assigned to our patients during therapy. Hyperuricaemia, probably related to renal urate retention, is often associated with arterial hypertension (Cannon, Statson, De Martini, Summers & Laragh, 1966) . Prolonged thiazide therapy may also cause hyperuricaemia in about 60% of patients by decreasing urate clearance (Hull, Suki, Rector & Seldin, 1967) . Diuretic drugs and uric acid might compete for active tubular secretion; moreover, hyperuricaemia might be due partly to extracelMar fluid volume contraction caused by diuretics. The accumulation of uric acid may lead to gouty arthritis and deposition of urate in the renal parenchyma ('gouty kidney'). Hyperuricaemia may also be a relatively common contributing factor in the pathogenesis of interstitial nephritis (Murray & Goldberg, 1976) . These lesions may perpetuate a vicious circle:
Discussion
hypertension + urate deposition -. parenchymal and/or vascular renal disease + hypertension Tienilic acid is a moderately potent diuretic and antihypertensive agent. Because of its strong uricosuric and hypouricaemic effect, it appears particularly promising in the long-term therapy for hypertensive patients.
